Implementing a Sodium-Glucose Cotransporter 2 Inhibitor Module With a Software Tool (Future Health Today):...

Area of Science:

• Health Informatics
• Primary Care Medicine
• Clinical Decision Support Systems

Background:

• Primary care is crucial for managing type 2 diabetes.
• Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular and renal complications.
• Future Health Today (FHT) is a clinical decision support software enhancing chronic disease management.

Purpose of the Study:

• To explore barriers and enablers for implementing an SGLT2 inhibitor module in FHT software.
• To understand clinic staff experiences with a tool designed to improve SGLT2 inhibitor prescribing.
• To identify factors influencing the adoption of new clinical decision support tools in primary care.

Main Methods:

• Qualitative study involving interviews with clinic staff.
• Thematic analysis guided by the Clinical Performance Feedback Intervention Theory.
• Exploration of user experiences with a specific SGLT2 inhibitor prescribing support tool.

Main Results:

• 16 interviews were completed, identifying key themes.
• Enablers included workflow integration, clinical relevance, and active module delivery.
• Barriers comprised competing priorities, insufficient staff engagement, and knowledge gaps regarding SGLT2 inhibitors.

Conclusions:

• Clinical decision support tools offer recognized benefits for type 2 diabetes management.
• Barriers to usability and actionability were identified, impacting module effectiveness.
• Successful implementation can optimize SGLT2 inhibitor use and improve patient outcomes in primary care.